PMDA — authorised 25 November 2011
- Marketing authorisation holder: Shiseido Company, Limited
- Status: approved
PMDA authorised Estrace on 25 November 2011
Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.
Yes. PMDA authorised it on 25 November 2011.
Shiseido Company, Limited holds the Japanese marketing authorisation.